Treatment of Post-transplant Relapse of FLT3-ITD Mutated AML Using 5-Azacytidine and Sorafenib Bitherapy

Publication date: Available online 11 January 2017 Source:Clinical Lymphoma Myeloma and Leukemia Author(s): Sid Selim, Jerome Rey, Aude Charbonnier, Evelyne D'Incan, Bilal Mohty, Didier Blaise, Norbert Vey
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research